DA Davidson Upgrades Oracle to Buy, $180 Price Target
DA Davidson upgrades Oracle to Buy, citing strong OpenAI outlook and reduced risks, with a $180 price target.
Already have an account? Sign in.
DA Davidson upgrades Oracle to Buy, citing strong OpenAI outlook and reduced risks, with a $180 price target.
AxoGen shares rose after Cigna will cover its nerve graft from Apr 2026, helping more patients get nerve repair after surgery.
Alcoa posted mixed Q1 results: profits rose, sales and shipments fell, but it expects recovery and stronger performance in Q2.
Reed Hastings leaves Netflix’s board after 30 years. Q1 beats expectations, but shares fall on Q2 outlook. Growth and ads drive strong results.